Loan payable, related party (Details Narrative) (Mymd Pharmaceuticals Inc.) - Secured Promissory Note [Member] - USD ($) |
1 Months Ended | |||||
|---|---|---|---|---|---|---|
Jan. 31, 2021 |
Nov. 30, 2020 |
Feb. 25, 2021 |
Jan. 21, 2021 |
Dec. 31, 2020 |
Nov. 11, 2020 |
|
| Loan payable, related party | $ 1,200,000 | |||||
| Subsequent Event [Member] | ||||||
| Loan payable, related party | $ 1,200,000 | $ 600,000 | ||||
| Mymd Pharmaceuticals Inc. [Member] | ||||||
| Debt face amount | $ 3,000,000 | $ 3,000,000 | ||||
| Debt instrument, interest rate, | 5.00% | |||||
| Debt instrument, maturity date | Apr. 15, 2022 | |||||
| Loan payable, related party | $ 1,200,000 | |||||
| Mymd Pharmaceuticals Inc. [Member] | Subsequent Event [Member] | ||||||
| Proceeds from Notes Payable | $ 600,000 | |||||
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a borrowing supported by a written promise to pay an obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|